Tapewire

Nasdaq · USD

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Export transactions ↓
Tapewire entity
6447
SEC CIK
0001005286
Parsed reports
374

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2021 Filed Mar 17, 2021 00:05 UTC
Kimball DawnChief People Officer
GrantCommon Stock 5,000 $12.09 $60,450.00
Disclosure

SEC source: 0001593968-21-000961 · primary_01.xml · nonDerivative · entry 1

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
March 12, 2021 Filed Mar 19, 2021 17:55 UTC Amendment
Kimball DawnChief People Officer
Disposition to issuerCommon Stock 6,453 $12.09 $78,016.77
Disclosure

SEC source: 0001593968-21-000984 · primary_01.xml · nonDerivative · entry 4

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,679

Read SEC document
March 12, 2021 Filed Mar 19, 2021 17:55 UTC Amendment
Kimball DawnChief People Officer
Disposition to issuerCommon Stock 2,476 $12.09 $29,934.84
Disclosure

SEC source: 0001593968-21-000984 · primary_01.xml · nonDerivative · entry 3

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,132

Read SEC document
March 12, 2021 Filed Mar 19, 2021 17:55 UTC Amendment
Kimball DawnChief People Officer
GrantCommon Stock 13,608 $12.09 $164,520.72
Disclosure

SEC source: 0001593968-21-000984 · primary_01.xml · nonDerivative · entry 2

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,608

Read SEC document
March 12, 2021 Filed Mar 19, 2021 17:55 UTC Amendment
Kimball DawnChief People Officer
GrantCommon Stock 5,000 $12.09 $60,450.00
Disclosure

SEC source: 0001593968-21-000984 · primary_01.xml · nonDerivative · entry 1

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
February 11, 2021 Filed Feb 12, 2021 18:19 UTC
Morberg John DChief Financial Officer
PurchaseCommon Stock 1,400 $11.88 $16,632.00
Disclosure

SEC source: 0001593968-21-000434 · primary_01.xml · nonDerivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,400

Read SEC document
February 10, 2021 Filed Feb 11, 2021 17:52 UTC
Morberg John DChief Financial Officer
PurchaseCommon Stock 2,000 $11.64 $23,280.00
Disclosure

SEC source: 0001593968-21-000404 · primary_01.xml · nonDerivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.62 to $11.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
February 09, 2021 Filed Feb 10, 2021 17:47 UTC
Morberg John DChief Financial Officer
PurchaseCommon Stock 2,000 $12.06 $24,120.00
Disclosure

SEC source: 0001593968-21-000398 · primary_01.xml · nonDerivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.04 to $12.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
February 08, 2021 Filed Feb 9, 2021 17:57 UTC
Morberg John DChief Financial Officer
PurchaseCommon Stock 2,000 $10.97 $21,940.00
Disclosure

SEC source: 0001593968-21-000380 · primary_01.xml · nonDerivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.97 to $11.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
February 05, 2021 Filed Feb 8, 2021 22:51 UTC
Morberg John DChief Financial Officer
PurchaseCommon Stock 2,000 $10.87 $21,740.00
Disclosure

SEC source: 0001593968-21-000375 · primary_01.xml · nonDerivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.86 to $10.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
January 19, 2021 Filed Jan 19, 2021 22:48 UTC
Bolles Albert D.Chief Executive Officer
PurchaseCommon Stock 10,000 $10.98 $109,800.00
Disclosure

SEC source: 0001593968-21-000152 · primary_01.xml · nonDerivative · entry 1

Bolles Albert D. · CIK 0001603163 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,152

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.80 to $11.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
January 18, 2021 Filed Jan 21, 2021 22:21 UTC
Morberg John DChief Financial Officer
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 78,742 $10.83 Strike: $10.83 $852,775.86
Disclosure

SEC source: 0001593968-21-000156 · primary_01.xml · derivative · entry 3

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,742

Underlying: Common Stock · 78,742 shares

Expires 2028-01-18

Read SEC document
January 18, 2021 Filed Jan 21, 2021 22:21 UTC
Morberg John DChief Financial Officer
GrantIncentive Stock Option (Right to Buy) · Derivative 21,258 $10.83 Strike: $10.83 $230,224.14
Disclosure

SEC source: 0001593968-21-000156 · primary_01.xml · derivative · entry 2

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,258

Underlying: Common Stock · 21,258 shares

Expires 2028-01-18

Read SEC document
January 18, 2021 Filed Jan 21, 2021 22:21 UTC
Morberg John DChief Financial Officer
GrantRestricted Stock Unit · Derivative 17,500 $0.00 $0.00
Disclosure

SEC source: 0001593968-21-000156 · primary_01.xml · derivative · entry 1

Morberg John D · CIK 0001345964 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · derivative.exercise_date: No exercisable date for this type of award

F3 · derivative.expiration_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 20:26 UTC
OBUS NELSONDirector
PurchaseCommon Stock 13,600 $10.74 $146,064.00
Disclosure

SEC source: 0001593968-21-000126 · primary_01.xml · nonDerivative · entry 2

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wynnefield Capital

Disclosed balance after: 2,905,300

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.65 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 20:26 UTC
OBUS NELSONDirector
PurchaseCommon Stock 6,400 $10.81 $69,184.00
Disclosure

SEC source: 0001593968-21-000126 · primary_01.xml · nonDerivative · entry 1

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wynnefield Capital

Disclosed balance after: 2,891,700

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.75 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
October 19, 2020 Filed Oct 21, 2020 00:25 UTC
McLaughlin Brian FChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002079 · primary_01.xml · derivative · entry 3

McLaughlin Brian F · CIK 0001790969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 19, 2017.

F3 · derivative.exercise_date: The restricted stock units vested on October 19, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 19, 2020.

Read SEC document
October 19, 2020 Filed Oct 21, 2020 00:25 UTC
McLaughlin Brian FChief Financial Officer
Tax withholdingCommon Stock 2,479 $10.09 $25,013.11
Disclosure

SEC source: 0001593968-20-002079 · primary_01.xml · nonDerivative · entry 2

McLaughlin Brian F · CIK 0001790969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,053

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 19, 2020 Filed Oct 21, 2020 00:25 UTC
McLaughlin Brian FChief Financial Officer
Exercise / conversionCommon Stock 5,000 $10.09 $50,450.00
Disclosure

SEC source: 0001593968-20-002079 · primary_01.xml · nonDerivative · entry 1

McLaughlin Brian F · CIK 0001790969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:25 UTC Exercise / conversionRestricted Stock Unit · Derivative 7,334 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002074 · primary_01.xml · derivative · entry 2

HOUDE LOVAS KATRINA · CIK 0001269294 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,334 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:25 UTC GrantCommon Stock 7,334 $10.36 $75,980.24
Disclosure

SEC source: 0001593968-20-002074 · primary_01.xml · nonDerivative · entry 1

HOUDE LOVAS KATRINA · CIK 0001269294 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,334

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:24 UTC
OBUS NELSONDirector
Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002073 · primary_01.xml · derivative · entry 2

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:24 UTC
OBUS NELSONDirector
GrantCommon Stock 2,200 $10.36 $22,792.00
Disclosure

SEC source: 0001593968-20-002073 · primary_01.xml · nonDerivative · entry 1

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,115

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:20 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002071 · primary_01.xml · derivative · entry 2

Carosella Deborah D · CIK 0001701600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:20 UTC GrantCommon Stock 2,200 $10.36 $22,792.00
Disclosure

SEC source: 0001593968-20-002071 · primary_01.xml · nonDerivative · entry 1

Carosella Deborah D · CIK 0001701600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,226

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:19 UTC Exercise / conversionRestricted Stock Unit · Derivative 5,501 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002070 · primary_01.xml · derivative · entry 2

MACALUSO CHARLES · CIK 0001199536 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,501 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:19 UTC GrantCommon Stock 5,501 $10.36 $56,990.36
Disclosure

SEC source: 0001593968-20-002070 · primary_01.xml · nonDerivative · entry 1

MACALUSO CHARLES · CIK 0001199536 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,501

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:17 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002069 · primary_01.xml · derivative · entry 2

Powell Andrew Kenneth William · CIK 0001304113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:17 UTC GrantCommon Stock 2,200 $10.36 $22,792.00
Disclosure

SEC source: 0001593968-20-002069 · primary_01.xml · nonDerivative · entry 1

Powell Andrew Kenneth William · CIK 0001304113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,115

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:14 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002068 · primary_01.xml · derivative · entry 2

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:14 UTC GrantCommon Stock 2,200 $10.36 $22,792.00
Disclosure

SEC source: 0001593968-20-002068 · primary_01.xml · nonDerivative · entry 1

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,707

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:13 UTC Exercise / conversionRestricted Stock Unit · Derivative 5,501 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002067 · primary_01.xml · derivative · entry 2

Barbarosh Craig A. · CIK 0001472457 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,501 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 19, 2020 20:13 UTC GrantCommon Stock 5,501 $10.36 $56,990.36
Disclosure

SEC source: 0001593968-20-002067 · primary_01.xml · nonDerivative · entry 1

Barbarosh Craig A. · CIK 0001472457 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 5,501

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 15, 2020 Filed Oct 20, 2020 19:18 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002078 · primary_01.xml · derivative · entry 2

PANKOPF TONIA L · CIK 0001268528 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires 2020-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 15, 2019.

F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020.

F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020.

Read SEC document
October 15, 2020 Filed Oct 20, 2020 19:18 UTC GrantCommon Stock 2,200 $10.36 $22,792.00
Disclosure

SEC source: 0001593968-20-002078 · primary_01.xml · nonDerivative · entry 1

PANKOPF TONIA L · CIK 0001268528 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,237

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 22:55 UTC
FRANK FREDDirector
Exercise / conversionRestricted Stock Unit · Derivative 8,303 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002036 · primary_01.xml · derivative · entry 4

FRANK FRED · CIK 0001181155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,303 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F4 · shares: The restricted stock units were granted on June 1, 2020.

F3 · derivative.exercise_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors.

F3 · derivative.expiration_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 22:55 UTC
FRANK FREDDirector
Exercise / conversionRestricted Stock Unit · Derivative 2,200 $0.00 $0.00
Disclosure

SEC source: 0001593968-20-002036 · primary_01.xml · derivative · entry 3

FRANK FRED · CIK 0001181155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · shares: The restricted stock units were granted on October 14, 2019.

F3 · derivative.exercise_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors.

F3 · derivative.expiration_date: Vesting of restricted stock units accelerated on October 14, 2020 by reason of retirement from position on the Board of Directors.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 22:55 UTC
FRANK FREDDirector
GrantCommon Stock 2,200 $10.42 $22,924.00
Disclosure

SEC source: 0001593968-20-002036 · primary_01.xml · nonDerivative · entry 2

FRANK FRED · CIK 0001181155 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · In Trust

Disclosed balance after: 76,527

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 22:55 UTC
FRANK FREDDirector
GrantCommon Stock 8,303 $10.42 $86,517.26
Disclosure

SEC source: 0001593968-20-002036 · primary_01.xml · nonDerivative · entry 1

FRANK FRED · CIK 0001181155 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · In Trust

Disclosed balance after: 74,327

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

Read SEC document
October 14, 2020 Filed Oct 15, 2020 23:00 UTC
OBUS NELSONDirector
PurchaseCommon Stock 8,638 $10.32 $89,144.16
Disclosure

SEC source: 0001593968-20-002037 · primary_01.xml · nonDerivative · entry 2

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wynnefield Capital

Disclosed balance after: 2,885,300

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.20 to $10.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 21:19 UTC GrantRestricted Stock Unit · Derivative 5,398 Not disclosed Not disclosed
Disclosure

SEC source: 0001593968-20-002056 · primary_01.xml · derivative · entry 1

EDWARDS JEFFREY L · CIK 0001190642 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,398

Underlying: Common Stock · 5,398 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 21:16 UTC GrantRestricted Stock Unit · Derivative 5,398 Not disclosed Not disclosed
Disclosure

SEC source: 0001593968-20-002055 · primary_01.xml · derivative · entry 1

Schechter Joshua · CIK 0001336601 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,398

Underlying: Common Stock · 5,398 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.

Read SEC document
October 14, 2020 Filed Oct 16, 2020 21:15 UTC GrantRestricted Stock Unit · Derivative 5,398 Not disclosed Not disclosed
Disclosure

SEC source: 0001593968-20-002054 · primary_01.xml · derivative · entry 1

Walsh Patrick D · CIK 0001720568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,398

Underlying: Common Stock · 5,398 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.

Read SEC document
October 13, 2020 Filed Oct 15, 2020 23:00 UTC
OBUS NELSONDirector
PurchaseCommon Stock 1,362 $10.19 $13,878.78
Disclosure

SEC source: 0001593968-20-002037 · primary_01.xml · nonDerivative · entry 1

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wynnefield Capital

Disclosed balance after: 2,876,662

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.15 to $10.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 16:28 UTC
Bolles Albert D.Chief Executive Officer
GrantPerformance-Based Restricted Stock Units · Derivative 45,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-014172 · wf-form4_160165612202773.xml · derivative · entry 1

Bolles Albert D. · CIK 0001603163 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2024-09-30

F1 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · shares: Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.

F3 · derivative.exercise_date: The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock price milestones.

F2 · derivative.underlying_shares: Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.

F2 · balance_after: Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.

Read SEC document
July 23, 2020 Filed Jul 28, 2020 00:10 UTC
Burgess Timothy PSenior VP of Supply Chain
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 6,874 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001593968-20-001672 · primary_01.xml · derivative · entry 2

Burgess Timothy P · CIK 0001782988 · Senior VP of Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,874

Underlying: Common Stock · 6,874 shares

Expires 2027-07-23

Read SEC document
July 23, 2020 Filed Jul 28, 2020 00:10 UTC
Burgess Timothy PSenior VP of Supply Chain
GrantIncentive Stock Option (Right to Buy) · Derivative 28,126 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001593968-20-001672 · primary_01.xml · derivative · entry 1

Burgess Timothy P · CIK 0001782988 · Senior VP of Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,126

Underlying: Common Stock · 28,126 shares

Expires 2027-07-23

Read SEC document
July 23, 2020 Filed Jul 28, 2020 00:04 UTC
McLaughlin Brian FChief Financial Officer
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 64,173 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001593968-20-001671 · primary_01.xml · derivative · entry 2

McLaughlin Brian F · CIK 0001790969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,173

Underlying: Common Stock · 64,173 shares

Expires 2027-07-23

Read SEC document
July 23, 2020 Filed Jul 28, 2020 00:04 UTC
McLaughlin Brian FChief Financial Officer
GrantIncentive Stock Option (Right to Buy) · Derivative 5,827 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001593968-20-001671 · primary_01.xml · derivative · entry 1

McLaughlin Brian F · CIK 0001790969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,827

Underlying: Common Stock · 5,827 shares

Expires 2027-07-23

Read SEC document
July 23, 2020 Filed Jul 28, 2020 00:01 UTC
Kimball DawnChief People Officer
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 9,920 $0.00 Strike: $9.40 $0.00
Disclosure

SEC source: 0001593968-20-001670 · primary_01.xml · derivative · entry 2

Kimball Dawn · CIK 0001791709 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,920

Underlying: Common Stock · 9,920 shares

Expires 2027-07-23

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.